Drug recall · February 18, 2026
Cetrorelix Acetate for Injection recall
Why: Defective Delivery System: Missing or duplicated needles within the injection kit
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
- Lots / codes
Lot Q4E0112A, Exp.: 30 Apr 2027
- Quantity
- 16,477 kits
- Company
- Meitheal Pharmaceuticals, Inc, Chicago, IL
- Distribution
- U.S. Nationwide
- Initiated
- February 9, 2026 · Voluntary: Firm initiated
- Classified
- February 23, 2026
- Reported
- February 18, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cetrorelix
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.